Neoplasias Mielodisplásicas
Memorial Sloan Kettering Cancer Center
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (2)
2013
-
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells
Leukemia, Vol. 27, Núm. 11, pp. 2177-2186
-
Toll-like receptor alterations in myelodysplastic syndrome
Leukemia, Vol. 27, Núm. 9, pp. 1832-1840